相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of hematopoietic stem cell transplantation for relapsed acute promyelocytic leukemia: A retrospective analysis of JALSG-APL97
Hiroyuki Fujita et al.
CANCER SCIENCE (2013)
Outcomes in Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Treated With or Without Autologous or Allogeneic Hematopoietic Stem Cell Transplantation
Naveen Pemmaraju et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2013)
Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia
Akihiro Tomita et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
High efficacy of arsenic trioxide plus all-trans retinoic acid based induction and maintenance therapy in newly diagnosed acute promyelocytic leukemia
Yinjun Lou et al.
LEUKEMIA RESEARCH (2013)
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
F. Lo-Coco et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy
Ezhilarasi Chendamarai et al.
BLOOD (2012)
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)
Harry J. Iland et al.
BLOOD (2012)
Treatment advances have not improved the early death rate in acute promyelocytic leukemia
James Scott McClellan et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia in the ATRA and ATO era
Safaa M. Ramadan et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid
Jae H. Park et al.
BLOOD (2011)
Efficacy of prolonged therapy with combined arsenic trioxide and ATRA for relapse of acute promyelocytic leukemia
Massimo Breccia et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Acute Promyelocytic Leukemia at Time of Relapse Commonly Demonstrates Cytogenetic Evidence of Clonal Evolution and Variability in Blast Immunophenotypic Features
Nikolay D. Dimov et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience
Lionel Ades et al.
BLOOD (2010)
Comparison of Clinical Outcomes of Patients with Relapsed Acute Promyelocytic Leukemia Induced with Arsenic Trioxide and Consolidated with Either an Autologous Stem Cell Transplant or an Arsenic Trioxide-Based Regimen
Rajasekar Thirugnanam et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Miguel A. Sanz et al.
BLOOD (2009)
Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy
David Grimwade et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
Jiong Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Acute promyelocytic leukemia: from highly fatal to highly curable
Zhen-Yi Wang et al.
BLOOD (2008)
Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation
M. A. Sanz et al.
BONE MARROW TRANSPLANTATION (2007)
Treatment of relapsed or refractory acute promyelocytic leukemia
Martin S. Tallman
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2007)
All-trans retinoic acid/AS2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia
ZX Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
BD Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia -: A Europe Against Cancer Program
J Gabert et al.
LEUKEMIA (2003)
Arsenic trioxide in comparison with chemotherapy and bone marrow transplantation for the treatment of relapsed acute promyelocytic leukaemia
WY Au et al.
ANNALS OF ONCOLOGY (2003)
Combined arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia recurring from previous relapses successfully treated using arsenic trioxide
WY Au et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
分享论文
